Multiple Sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS) that affects 250,000-350,000 people in the United States. Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated disorder with clinical and pathological features similar to MS, making it a highly relevant animal model for the study of MS. In addition to the signal the encephalitogenic T cell receives through the T cell receptor (TCR), a second signal, termed co-stimulation, is required for complete T cell activation. The B7 family of cell surface molecules is capable of providing this second signal to T cells via two receptors, CD28 and CTLA-4. It is also known that activated or memory T cells are less dependent on co-stimulation through the B7:CD28/CTLA-4 pathway. Experimental evidence suggests that T cell reactive with myelin components are involved in the pathogenesis of EAE and possibly MS. Building upon our prior work in the EAE model, we will test the hypothesis that myelin-reactive T cells, which are relevant to the pathogenesis of CNS inflammatory demyelination, can be distinguished form naive, naive, myelin-reactive T cells by a lack of dependence upon co-stimulation for activation. To accomplish this, we will examine the requirements for the activation of myelin-reactive T cells over time in both the EAE model and in patients with MS. Using sophisticated techniques in molecular biology such as single strand conformation polymorphism (SSCP) analysis, we will determine whether the co- stimulation-independent, myelin-reactive T cells we observe in vitro are actually expanded in MS patients in vivo, implicating these specific T cells in the pathophysiology of the disease. Our studies will also determine the role of the B7: CD28/CTLA-4 pathway in the activation of disease using T cells in vivo, and their role in the regulation of disease in mice normally resistant to EAE. We will also continue our studies examining mechanisms of peripheral tolerance in the EAE model, focusing on co-stimulatory pathways. The studies proposed will advance our understanding of the pathophysiology of MS and may be applicable for the design of new treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
7R01NS037513-02
Application #
6142123
Study Section
Special Emphasis Panel (ZRG1-BDCN-4 (01))
Program Officer
Kerza-Kwiatecki, a P
Project Start
1998-12-01
Project End
2002-11-30
Budget Start
1999-07-01
Budget End
1999-11-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Neurology
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Smith, Kristen M; Guerau-de-Arellano, Mireia; Costinean, Stefan et al. (2012) miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol 189:1567-76
Peng, Haiyan; Guerau-de-Arellano, Mireia; Mehta, Veela B et al. (2012) Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor ?B (NF-?B) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling. J Biol Chem 287:28017-26
Biegler, Brian W; Yan, Shirley X; Ortega, Sterling B et al. (2011) Clonal composition of neuroantigen-specific CD8+ and CD4+ T-cells in multiple sclerosis. J Neuroimmunol 234:131-40
Lovett-Racke, Amy E; Yang, Yuhong; Racke, Michael K (2011) Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim Biophys Acta 1812:246-51
Ghoreschi, Kamran; Brück, Jürgen; Kellerer, Christina et al. (2011) Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med 208:2291-303
Huss, David J; Winger, Ryan C; Cox, Gina Mavrikis et al. (2011) TGF-? signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur J Immunol 41:2987-96
Guerau-de-Arellano, Mireia; Smith, Kristen M; Godlewski, Jakub et al. (2011) Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 134:3578-89
Huss, David J; Winger, Ryan C; Peng, Haiyan et al. (2010) TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10. J Immunol 184:5628-36
Yang, Yuhong; Liu, Yue; Wei, Ping et al. (2010) Silencing Nogo-A promotes functional recovery in demyelinating disease. Ann Neurol 67:498-507
Racke, Michael K (2010) Understanding the effects of FTY720 on leukocyte trafficking. Arch Neurol 67:1433-4

Showing the most recent 10 out of 43 publications